Loss of miR-29 in myoblasts contributes to dystrophic muscle pathogenesis

Molecular Therapy

Volumn 20, Issue 6, 2012, Pages 1222-1233

  Wang, Lijun ^a   Zhou, Liang ^a   Jiang, Peiyong ^a   Lu, Leina ^a   Chen, Xiaona ^a   Lan, Huiyao ^a   Guttridge, Denis C ^b   Sun, Hao ^a   Wang, Huating ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD68 ANTIGEN; COLLAGEN; COLLAGEN 1A1; COLLAGEN 3A1; MICROFIBRILLAR ASSOCIATED PROTEIN 5; MICRORNA; MICRORNA 29; MICRORNA 29A; MICRORNA 29B; MICRORNA 29C; MYOD PROTEIN; MYOGENIN; SCLEROPROTEIN; TRANSCRIPTION FACTOR PAX7; TRANSCRIPTION FACTOR YY1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VIMENTIN;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; DUCHENNE MUSCULAR DYSTROPHY; FIBROGENESIS; GENE EXPRESSION REGULATION; GENE FUNCTION; INTRACELLULAR SIGNALING; MOUSE; MUSCLE MASS; MUSCLE REGENERATION; MYOBLAST; NONHUMAN; PROTEIN EXPRESSION; RNA EXTRACTION; RNA SEQUENCE;

MUS;

EID: 84862812760     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2012.35     Document Type: Article

References (50)

1. Gregory, RI, Chendrimada, TP, Cooch, N and Shiekhattar, R (2005). Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell 123: 631-640. (Pubitemid 41608466)
2. Hutvagner, G (2005). Small RNA asymmetry in RNAi: function in RISC assembly and gene regulation. FEBS Lett 579: 5850-5857.
3. Miska, EA (2005). How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev 15: 563-568.
4. Shivdasani, RA (2006). MicroRNAs: regulators of gene expression and cell differentiation. Blood 108: 3646-3653.
5. Zhang, B, Wang, Q and Pan, X (2007). MicroRNAs and their regulatory roles in animals and plants. J Cell Physiol 210: 279-289. (Pubitemid 44956872)
6. Bader, AG, Brown, D and Winkler, M (2010). The promise of microRNA replacement therapy. Cancer Res 70: 7027-7030.
7. Blake, DJ, Weir, A, Newey, SE and Davies, KE (2002). Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol Rev 82: 291-329. (Pubitemid 34654455)
8. Cossu, G and Sampaolesi, M (2007). New therapies for Duchenne muscular dystrophy: challenges, prospects and clinical trials. Trends Mol Med 13: 520-526. (Pubitemid 350130348)
9. Deconinck, N and Dan, B (2007). Pathophysiology of duchenne muscular dystrophy: current hypotheses. Pediatr Neurol 36: 1-7. (Pubitemid 46427791)
10. Nowak, KJ and Davies, KE (2004). Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment. EMBO Rep 5: 872-876. (Pubitemid 350011231)
11. Serrano, AL and Muñoz-Cánoves, P (2010). Regulation and dysregulation of fibrosis in skeletal muscle. Exp Cell Res 316: 3050-3058.
12. Zhou, L and Lu, H (2010). Targeting fibrosis in Duchenne muscular dystrophy. J Neuropathol Exp Neurol 69: 771-776.
13. Border, WA, Noble, NA, Yamamoto, T, Harper, JR, Yamaguchi, Y, Pierschbacher, MD et al. (1992). Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature 360: 361-364. (Pubitemid 23000677)
14. Clouthier, DE, Comerford, SA and Hammer, RE (1997). Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice. J Clin Invest 100: 2697-2713. (Pubitemid 28007537)
15. Sime, PJ, Xing, Z, Graham, FL, Csaky, KG and Gauldie, J (1997). Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. J Clin Invest 100: 768-776. (Pubitemid 27371693)
16. Bernasconi, P, Torchiana, E, Confalonieri, P, Brugnoni, R, Barresi, R, Mora, M et al. (1995). Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine. J Clin Invest 96: 1137-1144.
17. Darby, IA and Hewitson, TD (2007). Fibroblast differentiation in wound healing and fibrosis. Int Rev Cytol 257: 143-179. (Pubitemid 46186476)
18. Li, Y and Huard, J (2002). Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle. Am J Pathol 161: 895-907. (Pubitemid 34988377)
19. Alexakis, C, Partridge, T and Bou-Gharios, G (2007). Implication of the satellite cell in dystrophic muscle fibrosis: a self-perpetuating mechanism of collagen overproduction. Am J Physiol, Cell Physiol 293: C661-C669. (Pubitemid 47235183)
20. Jiang, X, Tsitsiou, E, Herrick, SE and Lindsay, MA (2010). MicroRNAs and the regulation of fibrosis. FEBS J 277: 2015-2021.
21. Thum, T, Gross, C, Fiedler, J, Fischer, T, Kissler, S, Bussen, M et al. (2008). MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456: 980-984.
22. Roy, S, Khanna, S, Hussain, SR, Biswas, S, Azad, A, Rink, C et al. (2009). MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc Res 82: 21-29.
23. Roderburg, C, Urban, GW, Bettermann, K, Vucur, M, Zimmermann, H, Schmidt, S et al. (2011). Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 53: 209-218.
24. van Rooij, E, Sutherland, LB, Thatcher, JE, DiMaio, JM, Naseem, RH, Marshall, WS et al. (2008). Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA 105: 13027-13032.
25. Maurer, B, Stanczyk, J, Jüngel, A, Akhmetshina, A, Trenkmann, M, Brock, M et al. (2010). MicroRNA-29, a key regulator of collagen expression in systemic sclerosis. Arthritis Rheum 62: 1733-1743.
26. Cushing, L, Kuang, PP, Qian, J, Shao, F, Wu, J, Little, F et al. (2011). miR-29 is a major regulator of genes associated with pulmonary fibrosis. Am J Respir Cell Mol Biol 45: 287-294.
27. Cacchiarelli, D, Martone, J, Girardi, E, Cesana, M, Incitti, T, Morlando, M et al. (2010). MicroRNAs involved in molecular circuitries relevant for the Duchenne muscular dystrophy pathogenesis are controlled by the dystrophin/nNOS pathway. Cell Metab 12: 341-351.
28. Wang, H, Garzon, R, Sun, H, Ladner, KJ, Singh, R, Dahlman, J et al. (2008). NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell 14: 369-381.
29. Wang, H, Sun, H and Guttridge, DC (2009). microRNAs: novel components in a muscle gene regulatory network. Cell Cycle 8: 1833-1837.
30. Deconinck, AE, Rafael, JA, Skinner, JA, Brown, SC, Potter, AC, Metzinger, L et al. (1997). Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell 90: 717-727. (Pubitemid 27357963)
31. Buckingham, M (2006). Myogenic progenitor cells and skeletal myogenesis in vertebrates. Curr Opin Genet Dev 16: 525-532.
32. Bakkar, N, Wang, J, Ladner, KJ, Wang, H, Dahlman, JM, Carathers, M et al. (2008). IKK/NF-kB regulates skeletal myogenesis via a signaling switch to inhibit differentiation and promote mitochondrial biogenesis. J Cell Biol 180: 787-802. (Pubitemid 351397778)
33. Marioni, JC, Mason, CE, Mane, SM, Stephens, M and Gilad, Y (2008). RNA-seq: an assessment of technical reproducibility and comparison with gene expression arrays. Genome Res 18: 1509-1517.
34. Trapnell, C, Pachter, L and Salzberg, SL (2009). TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25: 1105-1111.
35. Trapnell, C, Williams, BA, Pertea, G, Mortazavi, A, Kwan, G, van Baren, MJ et al. (2010). Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 28: 511-515.
36. Gibson, MA, Finnis, ML, Kumaratilake, JS and Cleary, EG (1998). Microfibril-associated glycoprotein-2 (MAGP-2) is specifically associated with fibrillin-containing microfibrils but exhibits more restricted patterns of tissue localization and developmental expression than its structural relative MAGP-1. J Histochem Cytochem 46: 871-886.
37. Zhou, L, Porter, JD, Cheng, G, Gong, B, Hatala, DA, Merriam, AP et al. (2006). Temporal and spatial mRNA expression patterns of TGF-beta1, 2, 3 and TbetaRI, II, III in skeletal muscles of mdx mice. Neuromuscul Disord 16: 32-38. (Pubitemid 43089624)
38. Gosselin, LE, Williams, JE, Deering, M, Brazeau, D, Koury, S and Martinez, DA (2004). Localization and early time course of TGF-beta 1 mRNA expression in dystrophic muscle. Muscle Nerve 30: 645-653. (Pubitemid 39447289)
39. Li, Y, Foster, W, Deasy, BM, Chan, Y, Prisk, V, Tang, Y et al. (2004). Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis. Am J Pathol 164: 1007-1019. (Pubitemid 38235482)
40. Cencetti, F, Bernacchioni, C, Nincheri, P, Donati, C and Bruni, P (2010). Transforming growth factor-beta1 induces transdifferentiation of myoblasts into myofibroblasts via up-regulation of sphingosine kinase-1/S1P3 axis. Mol Biol Cell 21: 1111-1124.
41. Sato, K, Li, Y, Foster, W, Fukushima, K, Badlani, N, Adachi, N et al. (2003). Improvement of muscle healing through enhancement of muscle regeneration and prevention of fibrosis. Muscle Nerve 28: 365-372. (Pubitemid 37025346)
42. Sharbati, J, Lewin, A, Kutz-Lohroff, B, Kamal, E, Einspanier, R and Sharbati, S (2011). Integrated microRNA-mRNA-analysis of human monocyte derived macrophages upon Mycobacterium avium subsp. hominissuis infection. PLoS ONE 6: e20258.
43. Ma, F, Xu, S, Liu, X, Zhang, Q, Xu, X, Liu, M et al. (2011). The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-? Nat Immunol 12: 861-869.
44. Ono, Y, Sensui, H, Okutsu, S and Nagatomi, R (2007). Notch2 negatively regulates myofibroblastic differentiation of myoblasts. J Cell Physiol 210: 358-369. (Pubitemid 44956881)
45. Takeshita, F, Patrawala, L, Osaki, M, Takahashi, RU, Yamamoto, Y, Kosaka, N et al. (2010). Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes. Mol Ther 18: 181-187.
46. Wiggins, JF, Ruffino, L, Kelnar, K, Omotola, M, Patrawala, L, Brown, D et al. (2010). Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. Cancer Res 70: 5923-5930.
47. Guttridge, DC, Albanese, C, Reuther, JY, Pestell, RG and Baldwin, AS Jr (1999). NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cell Biol 19: 5785-5799. (Pubitemid 29339933)
48. Sengupta, S, den Boon, JA, Chen, IH, Newton, MA, Stanhope, SA, Cheng, YJ et al. (2008). MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, upregulating mRNAs encoding extracellular matrix proteins. Proc Natl Acad Sci USA 105: 5874-5878. (Pubitemid 351758465)
49. Wang, H, Hertlein, E, Bakkar, N, Sun, H, Acharyya, S, Wang, J et al. (2007). NF-kappaB regulation of YY1 inhibits skeletal myogenesis through transcriptional silencing of myofibrillar genes. Mol Cell Biol 27: 4374-4387. (Pubitemid 46906562)
50. Lu, L, Zhou, L, Chen, EZ, Sun, K, Jiang, P, Wang, L et al. (2012). A Novel YY1-miR-1 regulatory circuit in skeletal myogenesis revealed by genome-wide prediction of YY1-miRNA network. PLoS One 7: e27596.